Article Text

PDF

CFC transition
  1. D BROCKLEBANK
  1. Leighton Hospital
  2. Crewe CW1 4QJ, UK
  3. brocklebank{at}freeuk.com
  4. Department of Epidemiology and Public Health
  5. Bradford Royal Infirmary
  6. Bradford BD9 6RJ, UK
    1. J WRIGHT
    1. Leighton Hospital
    2. Crewe CW1 4QJ, UK
    3. brocklebank{at}freeuk.com
    4. Department of Epidemiology and Public Health
    5. Bradford Royal Infirmary
    6. Bradford BD9 6RJ, UK

      Statistics from Altmetric.com

      The editorial by Mark Everard1 provided an interesting viewpoint about inhaler therapy and delivery systems. However, the selective quotation of published trial evidence introduces the potential for bias in his conclusions. This is particularly apparent in the discussion on the ability of patients to use pressurised metered dose inhalers (pMDI) correctly. Like many other reviews in this field, selective citation of published papers leads to conclusions that alternative inhaler devices are used more effectively than pMDIs.

      We have recently completed an NHS sponsored systematic review of the published literature on the clinical and cost effectiveness of inhaler devices. One aspect, a systematic review of the clinical efficacy of pMDIs versus dry powder inhalers (DPIs),2 found that eight of the 14 clinical studies included in the review cited papers showing poor pMDI technique, including two citing the same paper as Everard by Crompton.3 The British Thoracic Society asthma guidelines4 also stress such problems: “Many patients are unable to use MDIs correctly . . . addition of a spacer device will reduce coordination problems”. Another aspect of the review was inhaler technique. Analysis of studies in which more than one type of inhaler device was assessed (six studies) showed that the “ideal” inhaler technique was found in 59% (95% CI 51 to 67) for DPI, in 43% (95% CI 36 to 50) for pMDI alone, and in 55% (95% CI 49 to 61) for pMDI with spacer. If the same outcome is considered after a period of inhaler technique teaching (20 studies), then the results are 65% (95% CI 59 to 71) for DPI, 63% (95% CI 60 to 67) for pMDI alone, and 74% (95% CI 53 to 88) for pMDI with spacer. There is marked heterogeneity within these studies and thus selective citation could show any one to be better than another.

      We agree that clinical testing of all inhaler devices is critical in informed decision making, but the editorial by Everard may imply that pMDIs are worse than other devices thus encouraging the use of perhaps even less well evaluated devices and at a greater financial cost—an outcome we are sure was not intended by the author.

      References

      View Abstract

      Request permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.